Stay updated with breaking news from Catalyst Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PARIS, FRANCE / ACCESSWIRE / July 11, 2023 / Abivax SA (PARIS:FR), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic
EQS-News: ABIVAX / Key word(s): Personnel Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as M...
/PRNewswire/ -- Exodigo, the most accurate non-intrusive subsurface imaging platform, today announced the results of its first project in France and its...
Biomedical engineer Cambre Kelly is developing solutions for orthopedic surgeons through multiple companies co-founded with her thesis advisor, Duke Professor Ken Gall.
Will a new Florida law just help housing developers make more money, or will it also make it easier for poor residents to pay their rent?